Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2012
03/28/2012CN102391995A Serum-free high density suspension perfusion culture technology of hybridoma cells
03/28/2012CN102391968A Streptomyces and its application in echinomycin production
03/28/2012CN102391967A Streptomycete strain and application thereof in production of actinomycin
03/28/2012CN102391377A Fusion protein capable of inducing and activating cancer targeting T-cells as well as preparation method and application of the fusion protein
03/28/2012CN102391361A Chickpea peptide with antioxidation effect and separation and purification method and application
03/28/2012CN101838661B Preparation method of high stability phycocyanin fuse fluorescent protein
03/28/2012CN101612389B Antiviral drug combination for livestock
03/28/2012CN101410517B Polynucleotide for producing recombinant protein in silkworm
03/28/2012CN101283103B Process for producing recombinant protein
03/28/2012CN101270379B Preparation method for abstracting collagen helical peptide from wood frog tissue
03/27/2012US8143058 Human CDR-grafted antibody and antibody fragment thereof
03/27/2012US8143049 Modified beta-glucosidases with improved stability
03/27/2012US8143047 Polypeptides of botryosphaeria rhodina
03/27/2012US8143039 Use of genetically modified organisms to generate biomass degrading enzymes
03/27/2012US8143036 Genetically modified microorganisms for producing itaconic acid with high yields
03/27/2012US8143028 Bacillus licheniformis B1, alkalophilic enzyme solution and method of producing the same
03/27/2012US8143027 Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity
03/27/2012US8143025 Antibodies against vascular endothelial growth factor receptor-1
03/27/2012US8143024 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
03/27/2012US8143023 Method for methanol independent induction from methanol inducible promoters in Pichia
03/27/2012US8143022 High production system for infectious hepatitis C virus particle
03/27/2012US8143017 Method of measuring the ability of a sample to withstand reactive oxygen species (ROSS)
03/27/2012US8143016 Methods of cleaving DNA with rationally-designed meganucleases
03/27/2012US8143015 Methods of cleaving DNA with rationally-designed meganucleases
03/27/2012US8142793 Norovirus and Sapovirus antigens
03/27/2012US8142790 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
03/27/2012CA2603671C Insp163 polypeptides for the treatment or prevention of cancer and arthritis
03/27/2012CA2486109C No-apical meristem proteins, polynucleotides and methods of use for same
03/27/2012CA2485698C Peptide amidation process
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2435812C Process and compositions for peptide, protein and peptidomimetic synthesis
03/27/2012CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
03/27/2012CA2362964C Fucosyl transferase gene
03/27/2012CA2245496C Receptor protein designated 2f1
03/22/2012WO2012037015A2 Novel lactobacillus salivarius and novel bacteriocin
03/22/2012WO2012036706A1 Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant clostridium difficle toxin b
03/22/2012WO2012035869A1 Method for extracting undenatured type ii collagen having active epitope
03/22/2012WO2012035115A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/22/2012WO2012007965A8 Enzyme for the production of optically pure 3 - quinuclidinol
03/22/2012WO2006046250A3 Compositions and methods for diagnosing and treating insulin resistance
03/22/2012US20120071631 Isolation and Characterization of Novel Green Fluorescent Proteins from Copepods
03/22/2012US20120071422 Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor
03/22/2012US20120070860 Combination stirrer
03/22/2012US20120070859 Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant clostridium difficile toxin b
03/22/2012US20120070857 ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070439 Antigen-binding proteins
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070436 Antigen-binding proteins
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070426 Peptide-based passive immunization therapy for the treatment of atherosclerosis
03/22/2012CA2811493A1 Method for separating target molecules or particles from fibrinogen-containing samples including blood components
03/22/2012CA2811206A1 Thermophilic mutants of trichoderma reesei endoglucanase i
03/22/2012CA2810390A1 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/22/2012CA2806322A1 Method for extracting undenatured type ii collagen having active epitope
03/21/2012EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells
03/21/2012EP2431391A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
03/21/2012EP2431387A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/21/2012EP2430165A1 Combinatorial engineering
03/21/2012EP2430164A2 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
03/21/2012EP2429582A2 Anti-human cd52 immunoglobulins
03/21/2012EP2185710B1 Eukaryotic promoters for gene expression
03/21/2012EP2152732B1 A modified secretion system to increase expression of polypeptides in bacteria
03/21/2012EP1708755B1 Transglutaminase mediated conjugation of peptides
03/21/2012EP1664321B1 Methods for expression and purification of immunotoxins
03/21/2012EP1650302B1 Protein capable of deposition onto extracellular matrix
03/21/2012EP1532142B1 Polypeptide cleavage process
03/21/2012EP1515988B1 Dna sequence and recombinant production of the grass pollen allergen phl p4
03/21/2012EP1461428B1 Method for producing hybrid antibodies
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012CN102387711A Protein hydrolysate compositions
03/21/2012CN102382872A Inactivated vaccine against Gram-negative bacteria, and its preparation method and application
03/21/2012CN102382193A Fusion protein capable of inducing and activating cancer-targeted T cells, preparation method and use thereof
03/21/2012CN101704886B Human alpha-defensin 5 antiviral active mutant polypeptide and preparation method and application
03/21/2012CN101381757B Solid fermentation preparation method of antibacterial peptide and application
03/21/2012CN101297966B Tumor vaccine for intestinal cancer containing rich chaperone-antigenic peptide complexes and preparation thereof
03/21/2012CN101280327B Synchronous aqueous enzymatic ultrasonic extraction for walnut oil and walnut protein peptide
03/21/2012CN101085345B High mannose proteins and methods of making high mannose proteins
03/21/2012CN101006176B Polypeptide having activity of unsaturating omega3-fatty acid, polynucleotide coding for the polypeptide and use thereof
03/20/2012US8138325 Using trangenic fusarium as bioreactor for propagation of heterologous polypeptides; improving heterologous gene expression
03/20/2012US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents
03/20/2012US8138316 Feline pancreatic lipase
03/20/2012US8138315 Anti-alpha V immunoliposome compositions, methods and uses
03/20/2012US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
03/20/2012US8138313 Treatment of tumors using specific anti-L1 antibody
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138310 Chimeric CD154 polypeptides
03/20/2012US8138307 Parkin interacting polypeptides and methods of use
03/20/2012US8137954 Erythropoietin compositions
03/20/2012US8137951 Methods for producing hyaluronan in a recombinant host cell
03/20/2012US8137944 Modified amylases from pseudomonas species, methods of making and uses thereof
03/20/2012US8137940 Method for production of biomass using a gluconobacter oxydans comprising an inactivated NADP dependent glucose dehydrogenase gene
03/20/2012US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
03/20/2012US8137933 Mammalian expression vector pUHAB
03/20/2012US8137932 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
03/20/2012US8137930 Attenuated Salmonella enterica serovar paratyphi A and uses thereof
03/20/2012US8137929 Basic protein purification tags from thermophilic bacteria
03/20/2012US8137928 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 1125